The four biotech stocks to watch this year

Nanosonics chief Michael Kavanagh wants to build Australia’s next medical device success story, replicating the success of his old employer, bionic ear maker Cochlear. Photo: Louie DouvisAfter a disappointing year for local biotechnology stocks, in which a number of high profile companies faltered on the back of poor clinical results or internal blunders, investors are scouring the sector for the […]